Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-23-047044

Chief Operating Officer sold 1,200,000 shares at an average $10.43 ($12,520,990)

  • Chief Operating Officer acquired 1,200,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric Chief Operating Officer 2023-10-02 Option exercise 10b5-1 +440,752 $3.85 $1,696,895 1,036,149 D
Venker Eric Chief Operating Officer 2023-10-02 Sale 10b5-1 −440,752 $10.80 $4,760,122 595,397 D
Venker Eric Chief Operating Officer 2023-10-03 Option exercise 10b5-1 +606,221 $3.85 $2,333,951 1,201,618 D
Venker Eric Chief Operating Officer 2023-10-03 Sale 10b5-1 −606,221 $10.25 $6,213,765 595,397 D
Venker Eric Chief Operating Officer 2023-10-04 Option exercise 10b5-1 +153,027 $3.85 $589,154 748,424 D
Venker Eric Chief Operating Officer 2023-10-05 Sale 10b5-1 −153,027 $10.11 $1,547,103 595,397 D
Derivatives
Venker Eric Chief Operating Officer 2023-10-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −440,752 13,382,432 D
Venker Eric Chief Operating Officer 2023-10-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −606,221 12,776,211 D
Venker Eric Chief Operating Officer 2023-10-04 Option exercise · Stock Option (Right to Buy) 10b5-1 −153,027 12,623,184 D
Open-market sales · 1,200,000 sh · avg $10.43 · $12,520,990
Loading xslF345X05/form4.xml…